Original news and analysis on international IP policy
By William New with Kaitlin Mara Government officials tasked this week through the United Nations with finding ways to develop and deliver treatment for overlooked diseases afflicting the globe’s poor are making uneven but persistent progress in negotiations. Debate has…
By Kaitlin Mara for Intellectual Property Watch As negotiators gather at the United Nations this week in Geneva to seek ways to boost innovation on neglected diseases disproportionately affecting poor people, a new study was released showing that commentators at…
By Sinfah Tunsarawuth for Intellectual Property Watch BANGKOK – Thailand has in its pipeline about 20 more items of various patented drugs that could be candidates for compulsory licences, allowing the government to exercise its right over the patent owners…
Par Paul Garwood Le cycle de négociations qui s’ouvre le mois prochain sur le plan des Nations Unies visant à améliorer l’accès aux médicaments pour les plus pauvres s’annonce difficile, les États et les régions étant divisés sur des sujets…
Por Paul Garwood A la ronda de negociaciones que tendrá lugar el próximo mes sobre un plan de las Naciones Unidas para impulsar el acceso a los medicamentos para los pobres del mundo le espera un camino difícil, en el…
By Paul Garwood Intellectual property can help improve public health, but drug research costs must be controlled so patients in poor countries can afford urgently needed medicines, a World Intellectual Property Organization symposium heard Wednesday. The Geneva-staged event, at which…
By Tove Iren S. Gerhardsen The World Health Organization is inviting participation in a six-week online public hearing from anyone interested in commenting on an ongoing process on how to ensure treatments for neglected diseases mainly found in developing countries.…
Par Tove Iren S. Gerhardsen Le nouveau document de négociation de l’Organisation mondiale de la santé (OMS) élaboré en vue du dernier cycle de ce qui est devenu un intense processus d’analyse de l’innovation médicale et de la propriété intellectuelle…
Por Tove Iren S. Gerhardsen El nuevo proyecto de documento de negociación de la Organización Mundial de la Salud (OMS) destinado a la última ronda de lo que se ha convertido en un proceso intenso de análisis sobre innovación de…
By Tove Iren S. Gerhardsen The World Health Organization’s (WHO) new draft negotiating document for the final round of what has become an intense process of analysing medicines innovation and intellectual property narrows the focus to about a dozen diseases…
By Tove Iren S. Gerhardsen A recent Organisation of Economic Cooperation and Development (OECD) high-level meeting on boosting the development of medicines for neglected diseases mainly found in developing countries, focused on a new model under which governments promise up-front…
By Tove Iren S. Gerhardsen NOORDWIJK, THE NETHERLANDS – Participants at a high-level meeting of the Organisation for Economic Cooperation and Development (OECD) meeting here informally agreed on an agenda for what needs to be done in the area of…